TG THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tg Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Tg Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 155M shares, a 2.55% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 155M +3.85M +2.55% Aug 5, 2024 10-Q 2024-08-09
Q1 2024 155M +5.15M +3.45% May 2, 2024 10-Q 2024-05-06
Q3 2023 151M +6.07M +4.18% Nov 1, 2023 10-Q 2023-11-06
Q2 2023 151M +5.7M +3.93% Aug 2, 2023 10-Q 2023-08-04
Q1 2023 149M +4.96M +3.44% May 2, 2023 10-Q 2023-05-08
Q3 2022 145M +2.4M +1.68% Nov 4, 2022 10-Q 2022-11-09
Q2 2022 145M +2.44M +1.71% Aug 2, 2022 10-Q 2022-08-09
Q1 2022 144M +2.97M +2.1% May 6, 2022 10-Q 2022-05-10
Q3 2021 143M +11.5M +8.71% Nov 3, 2021 10-Q 2021-11-08
Q2 2021 143M +16.2M +12.8% Jul 30, 2021 10-Q 2021-08-06
Q1 2021 141M +27.7M +24.4% May 4, 2021 10-Q 2021-05-10
Q3 2020 131M +31.9M +32.1% Nov 4, 2020 10-Q 2020-11-09
Q2 2020 127M +31.9M +33.7% Aug 5, 2020 10-Q 2020-08-10
Q1 2020 114M +22.9M +25.2% May 7, 2020 10-Q 2020-05-11
Q3 2019 99.6M +16.7M +20.1% Nov 5, 2019 10-Q 2019-11-12
Q2 2019 94.8M +11.9M +14.4% Aug 2, 2019 10-Q 2019-08-09
Q1 2019 90.8M +15.3M +20.2% May 3, 2019 10-Q 2019-05-10
Q3 2018 82.9M +12.2M +17.3% Nov 5, 2018 10-Q 2018-11-09
Q2 2018 82.8M +14M +20.3% Aug 3, 2018 10-Q 2018-08-09
Q1 2018 75.6M +18.7M +32.8% Mar 1, 2018 10-K 2018-03-15
Q3 2017 70.7M +15.9M +29.1% Nov 1, 2017 10-Q 2017-11-09
Q2 2017 68.8M +14.4M +26.4% Aug 1, 2017 10-Q 2017-08-09
Q1 2017 56.9M +2.81M +5.2% Mar 1, 2017 10-K 2017-03-16
Q3 2016 54.7M +2.21M +4.21% Nov 1, 2016 10-Q 2016-11-09
Q2 2016 54.5M +1.91M +3.63% Aug 1, 2016 10-Q 2016-08-09
Q1 2016 54.1M +7.55M +16.2% Mar 1, 2016 10-K 2016-03-15
Q3 2015 52.5M +8.56M +19.5% Nov 6, 2015 10-Q 2015-11-09
Q2 2015 52.5M +14.4M +37.8% Aug 4, 2015 10-Q 2015-08-10
Q1 2015 46.5M +12.2M +35.4% Mar 12, 2015 10-K 2015-03-16
Q3 2014 44M +10.5M +31.2% Nov 13, 2014 10-Q 2014-11-14
Q2 2014 38.1M +4.84M +14.6% Jul 21, 2014 10-Q 2014-07-24
Q1 2014 34.4M +8.55M +33.1% Mar 1, 2014 10-K 2014-03-07
Q3 2013 33.5M +8.44M +33.7% Nov 1, 2013 10-Q 2013-11-14
Q2 2013 33.3M +15.2M +84.3% Jul 29, 2013 10-Q 2013-08-09
Q1 2013 25.8M -259M -90.9% Mar 1, 2013 10-K 2013-03-21
Q3 2012 25.1M +17.7M +239% Nov 12, 2012 10-Q 2012-11-14
Q2 2012 18.1M +15.5M +595% Aug 2, 2012 10-Q/A 2012-09-07
Q1 2012 285M Mar 1, 2012 10-K 2012-03-14
Q3 2011 7.4M Nov 2, 2011 10-Q 2011-11-14
Q2 2011 2.6M Aug 9, 2011 10-Q/A 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.